Dr.  Peg Fletcher joins Mac Gordon, Director Bistatistics-Janssen and Scott Proestel, Acting Associate Director of the Biomedical Informatics and Regulatory Review Science Team at the FDA’s ‘in a panel discussion to explore the emerging challenge of managing and interpreting groups in different settings (e.g., Analysis of Similar Events, signal detection, etc.) and how groupings can be maintained.